[HTML] plos.org

[HTML][HTML] Aspirin better than clopidogrel on major adverse cardiovascular events reduction after ischemic stroke: a retrospective nationwide cohort study

AN Vidyanti, L Chan, CL Lin, CH Muo, CY Hsu… - PLoS …, 2019 - journals.plos.org
Background Several clinical trials reported that clopidogrel was superior to aspirin in
secondary stroke prevention by reducing the risk of major adverse cardiovascular events …
被引用次数：10 相关文章
[PDF] semanticscholar.org

[PDF][PDF] Aspirin better than clopidogrel on major adverse cardiovascular events reduction after ischemic stroke: A retrospective nationwide cohort study

AN Vidyanti, L Chan, CL Lin, CH Muo, CY Hsu… - PLoS …, 2019 - pdfs.semanticscholar.org
Background Several clinical trials reported that clopidogrel was superior to aspirin in
secondary stroke prevention by reducing the risk of major adverse cardiovascular events …

Aspirin better than clopidogrel on major adverse cardiovascular events reduction after ischemic stroke: A retrospective nationwide cohort study

AN Vidyanti, L Chan, CL Lin, CH Muo, CY Hsu… - PLoS ONE, 2019 - go.gale.com
Background Several clinical trials reported that clopidogrel was superior to aspirin in
secondary stroke prevention by reducing the risk of major adverse cardiovascular events …

Aspirin better than clopidogrel on major adverse cardiovascular events reduction after ischemic stroke: A retrospective nationwide cohort study.

AN Vidyanti, L Chan, CL Lin, CH Muo, CY Hsu… - PLoS …, 2019 - search.ebscohost.com
Background: Several clinical trials reported that clopidogrel was superior to aspirin in
secondary stroke prevention by reducing the risk of major adverse cardiovascular events …

Aspirin better than clopidogrel on major adverse cardiovascular events reduction after ischemic stroke: A retrospective nationwide cohort study

AN Vidyanti, L Chan, CL Lin, CH Muo, CY Hsu… - PLOS …, 2019 - econpapers.repec.org
Background: Several clinical trials reported that clopidogrel was superior to aspirin in
secondary stroke prevention by reducing the risk of major adverse cardiovascular events …

Aspirin better than clopidogrel on major adverse cardiovascular events reduction after ischemic stroke: A retrospective nationwide cohort study

AN Vidyanti, L Chan, CL Lin, CH Muo, CY Hsu… - PLOS ONE, 2019 - ideas.repec.org
Background: Several clinical trials reported that clopidogrel was superior to aspirin in
secondary stroke prevention by reducing the risk of major adverse cardiovascular events …

Aspirin better than clopidogrel on major adverse cardiovascular events reduction after ischemic stroke: A retrospective nationwide cohort study

AN Vidyanti, L Chan, CL Lin, CH Muo, CY Hsu… - PloS …, 2019 - pubmed.ncbi.nlm.nih.gov
Background Several clinical trials reported that clopidogrel was superior to aspirin in
secondary stroke prevention by reducing the risk of major adverse cardiovascular events …
[HTML] nih.gov

[HTML][HTML] Aspirin better than clopidogrel on major adverse cardiovascular events reduction after ischemic stroke: A retrospective nationwide cohort study

AN Vidyanti, L Chan, CL Lin, CH Muo, CY Hsu… - PLoS ONE, 2019 - ncbi.nlm.nih.gov
Background Several clinical trials reported that clopidogrel was superior to aspirin in
secondary stroke prevention by reducing the risk of major adverse cardiovascular events …

[引用][C] Aspirin better than clopidogrel on major adverse cardiovascular events reduction after ischemic stroke: A retrospective nationwide cohort study

AN Vidyanti, L Chan, CL Lin, CH Muo, CY Hsu… - PLoS …, 2019 - ui.adsabs.harvard.edu
Aspirin better than clopidogrel on major adverse cardiovascular events reduction after
ischemic stroke: A retrospective nationwide cohort study - NASA/ADS Now on home page ads …

Aspirin better than clopidogrel on major adverse cardiovascular events reduction after ischemic stroke: A retrospective nationwide cohort study

AN Vidyanti, L Chan, CL Lin, CH Muo, CY Hsu… - PLoS ONE, 2019 - hub.tmu.edu.tw
Background Several clinical trials reported that clopidogrel was superior to aspirin in
secondary stroke prevention by reducing the risk of major adverse cardiovascular events …